Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms von Kluetz, Paul G, Slagle, Ashley, Papadopoulos, Elektra J, Johnson, Laura Lee, Donoghue, Martha, Kwitkowski, Virginia E, Chen, Wen-Hung, Sridhara, Rajeshwari, Farrell, Ann T, Keegan, Patricia, Kim, Geoffrey, Pazdur, Richard

Volltext

Towards a consensus definition of allostatic load: a multi-cohort, multi-system, multi-biomarker individual participant data (IPD) meta-analysis von McCrory, Cathal, McLoughlin, Sinead, Layte, Richard, NiCheallaigh, Cliona, O’Halloran, Aisling M., Barros, Henrique, Berkman, Lisa F., Bochud, Murielle, M. Crimmins, Eileen, T. Farrell, Meagan, Fraga, Silvia, Grundy, Emily, Kelly-Irving, Michelle, Petrovic, Dusan, Seeman, Teresa, Stringhini, Silvia, Vollenveider, Peter, Kenny, Rose Anne

Volltext

The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients? von Farrell, T. P. J., Adams, N. C., Stenson, M., Carroll, P. A., Griffin, M., Connolly, E. M., O’Keeffe, S. A.

Volltext

FDA Approval: Blinatumomab von Przepiorka, Donna, Ko, Chia-Wen, Deisseroth, Albert, Yancey, Carolyn L, Candau-Chacon, Reyes, Chiu, Haw-Jyh, Gehrke, Brenda J, Gomez-Broughton, Candace, Kane, Robert C, Kirshner, Susan, Mehrotra, Nitin, Ricks, Tiffany K, Schmiel, Deborah, Song, Pengfei, Zhao, Ping, Zhou, Qing, Farrell, Ann T, Pazdur, Richard

Volltext

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma von Kasamon, Yvette L., de Claro, R. Angelo, Wang, Yaping, Shen, Yuan Li, Farrell, Ann T., Pazdur, Richard

Volltext

FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia von Norsworthy, Kelly J, By, Kunthel, Subramaniam, Sriram, Zhuang, Luning, Del Valle, Pedro L, Przepiorka, Donna, Shen, Yuan-Li, Sheth, Christopher M, Liu, Chao, Leong, Ruby, Goldberg, Kirsten B, Farrell, Ann T, Pazdur, Richard

Volltext

Systematic Review of PD‐1/PD‐L1 Inhibitors in Oncology: From Personalized Medicine to Public Health von Chang, Elaine, Pelosof, Lorraine, Lemery, Steven, Gong, Yutao, Goldberg, Kirsten B., Farrell, Ann T., Keegan, Patricia, Veeraraghavan, Janaki, Wei, Guo, Blumenthal, Gideon M., Amiri‐Kordestani, Laleh, Singh, Harpreet, Fashoyin‐Aje, Lola, Gormley, Nicole, Kluetz, Paul G., Pazdur, Richard, Beaver, Julia A., Theoret, Marc R.

Volltext

FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm von Jen, Emily Y, Gao, Xin, Li, Liang, Zhuang, Luning, Simpson, Natalie E, Aryal, Baikuntha, Wang, Rong, Przepiorka, Donna, Shen, Yuan Li, Leong, Ruby, Liu, Chao, Sheth, Christopher M, Bowen, Steven, Goldberg, Kirsten B, Farrell, Ann T, Blumenthal, Gideon M, Pazdur, Richard

Volltext

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma von HERNDON, Thomas M, DEISSEROTH, Albert, PALMBY, Todd R, JEE, Josephine, ADAMS, William, MAHAYNI, Houda, BROWN, Janice, DORANTES, Angelica, SRIDHARA, Rajeshwari, FARRELL, Ann T, PAZDUR, Richard, KAMINSKAS, Edvardas, KANE, Robert C, KOTI, Kallappa M, ROTHMANN, Mark D, HABTEMARIAM, Bahru, BULLOCK, Julie, BRAY, Jeffrey D, HAWES, Jessica

Volltext

FDA Drug Approval Summary: Azacitidine (5‐azacytidine, Vidaza™) for Injectable Suspension von Kaminskas, Edvardas, Farrell, Ann T., Wang, Yong‐Cheng, Sridhara, Rajeshwari, Pazdur, Richard

Volltext

United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior Therapy von Kane, Robert C, Farrell, Ann T, Sridhara, Rajeshwari, Pazdur, Richard

Volltext

Ophidiomycosis is related to seasonal patterns of reproduction, ecdysis, and thermoregulatory behavior in a free‐living snake species von Lind, C. M., Agugliaro, J., Lorch, J. M., Farrell, T. M.

Volltext

FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy von Bhatnagar, Vishal, Gormley, Nicole J., Luo, Lola, Shen, Yuan Li, Sridhara, Rajeshwari, Subramaniam, Sriram, Shen, Guoxiang, Ma, Lian, Shord, Stacy, Goldberg, Kirsten B., Farrell, Ann T., McKee, Amy E., Pazdur, Richard

Volltext

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma von Pulte, Elizabeth Dianne, Dmytrijuk, Andrew, Nie, Lei, Goldberg, Kirsten B., McKee, Amy E., Farrell, Ann T., Pazdur, Richard

Volltext

A comparison of mathematical models for phase-change in high-rate LiFePO4 cathodes von Dargaville, S., Farrell, T.W.

Volltext

Unity Makes Strength: Exploring Intraspecies and Interspecies Toxin Synergism between Phospholipases A2 and Cytotoxins von Pucca, Manuela B., Ahmadi, Shirin, Cerni, Felipe A., Ledsgaard, Line, Sørensen, Christoffer V., McGeoghan, Farrell T. S., Stewart, Trenton, Schoof, Erwin, Lomonte, Bruno, auf dem Keller, Ulrich, Arantes, Eliane C., Çalışkan, Figen, Laustsen, Andreas H.

Volltext

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma von Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Mitchell, Shan Sun, Sridhara, Rajeshwari, Pazdur, Richard

Volltext

Sorafenib for the Treatment of Advanced Renal Cell Carcinoma von KANE, Robert C, FARRELL, Ann T, SRIDHARA, Rajeshwari, GARVEY, Patricia, JUSTICE, Robert, PAZDUR, Richard, SABER, Haleh, SHENGHUI TANG, WILLIAMS, Gene, JEE, Josephine M, CHENGYI LIANG, BOOTH, Brian, CHIDAMBARAM, Nallaperumal, MORSE, David

Volltext

Effects of continuity of care by a primary midwife (caseload midwifery) on caesarean section rates in women of low obstetric risk: the COSMOS randomised controlled trial von McLachlan, HL, Forster, DA, Davey, MA, Farrell, T, Gold, L, Biro, MA, Albers, L, Flood, M, Oats, J, Waldenström, U

Volltext

The effect of primary midwife‐led care on women's experience of childbirth: results from the COSMOS randomised controlled trial von McLachlan, HL, Forster, DA, Davey, M‐A, Farrell, T, Flood, M, Shafiei, T, Waldenström, U

Volltext